Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1818 to 1867 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1818\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neighbor of cox4. [source:swissprot;acc:o43402]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
220.462\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.926\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01164\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1819\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein c14orf122 (cgi-112). [source:swissprot;acc:q9y3b6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1820\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding region containing protein 1 (hsrnaseb) (ssdna binding protein seb4) (cll-associated antigen kw-5). [source:swissprot;acc:q9h0z9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.874\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01152\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
240.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.085\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01151\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1823\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 2. [source:swissprot;acc:p51116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.386\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.086\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0115\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1824\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein alpha-1 subunit (capz alpha-1). [source:swissprot;acc:p52907]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.722\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.281\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1825\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 1. [source:swissprot;acc:p51114]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.386\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.086\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin nup43 (p42). [source:swissprot;acc:q8nfh3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.393\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.094\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01149\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1827\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoside diphosphate kinase 3 (ec 2.7.4.6) (ndk 3) (ndp kinase 3) (nm23-h3) (dr-nm23). [source:swissprot;acc:q13232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.219\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01147\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1828\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fragile x mental retardation 1 protein (protein fmr-1) (fmrp). [source:swissprot;acc:q06787]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.115\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1829\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cad protein [includes: glutamine-dependent carbamoyl-phosphate synthase (ec 6.3.5.5); aspartate carbamoyltransferase (ec 2.1.3.2); dihydroorotase (ec 3.5.2.3)]. [source:swissprot;acc:p27708]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.884\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01146\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1830\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
6-phosphofructokinase, muscle type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphofructokinase-m). [source:swissprot;acc:p08237]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
240.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.069\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01144\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1831\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein alpha-2 subunit (capz alpha-2). [source:swissprot;acc:p47755]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.746\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.328\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01139\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1832\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 4 (anion exchanger), member 1, adaptor protein; kidney anion exchanger adaptor protein; kanadaptin; lung cancer oncogene 3. [source:refseq;acc:nm\_018158]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
180.409\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
182.459\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01136\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1833\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 2 (cks-2). [source:swissprot;acc:p33552]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1835\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
golgi reassembly stacking protein 2; golgi reassembly stacking protein 2, 55 kda. [source:refseq;acc:nm\_015530]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
194.573\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.396\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01132\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1836\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribose 5-phosphate isomerase (ec 5.3.1.6) (phosphoriboisomerase). [source:swissprot;acc:p49247]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.821\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1837\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ketohexokinase (ec 2.7.1.3) (hepatic fructokinase). [source:swissprot;acc:p50053]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.984\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.446\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01124\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1838\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
purine nucleoside phosphorylase (ec 2.4.2.1) (inosine phosphorylase) (pnp). [source:swissprot;acc:p00491]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1839\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 2 (eukaryotic translation initiation factor 2 beta subunit) (eif-2-beta). [source:swissprot;acc:p20042]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.525\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01118\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1840\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-(apurinic or apyrimidinic site) lyase (ec 4.2.99.18) (ap endonuclease 1) (apex nuclease) (apen) (ref-1 protein). [source:swissprot;acc:p27695]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.882\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.544\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01116\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1841\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
presenilins associated rhomboid-like protein. [source:refseq;acc:nm\_018622]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
212.455\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
210.113\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01115\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1842\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-butyrobetaine,2-oxoglutarate dioxygenase (ec 1.14.11.1) (gamma-butyrobetaine hydroxylase) (gamma-bbh). [source:swissprot;acc:o75936]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1843\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase ih (ec 3.6.3.1) (atpase class i type 11a) (atpase is). [source:swissprot;acc:p98196]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1844\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
paired box protein pax-6 (oculorhombin) (aniridia, type ii protein). [source:swissprot;acc:p26367]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.773\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.417\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01109\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1845\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
abl-interactor 2; abl-interacting protein 1 (sh3-containing protein); abl binding protein 3; arg protein tyrosine kinase-binding protein; abl-interactor protein 2b; similar to spectrin sh3 domain binding protein 1. [source:refseq;acc:nm\_005759]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.077\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.702\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01106\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin sh3 domain binding protein 1; eps8 binding protein; interactor protein ablbp4; abl-interactor protein 1 long; nap1 binding protein. [source:refseq;acc:nm\_005470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.066\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.698\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01103\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1847\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brain protein 16. [source:refseq;acc:nm\_016458]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.811\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.195\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.011\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1848\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bile acid coenzyme a: amino acid n-acyltransferase; glycine n-choloyltransferase. [source:refseq;acc:nm\_001701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.441\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.064\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1849\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal acyl-coenzyme a thioester hydrolase 2a (ec 3.1.2.2) (peroxisomal long-chain acyl-coa thioesterase 2) (zap128). [source:swissprot;acc:p49753]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.074\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01097\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1850\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylyl cyclase-associated protein 1 (cap 1). [source:swissprot;acc:q01518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.931\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.587\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1851\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal acyl-coa thioesterase 2b; likely ortholog of mouse peroxisomal acyl-coa thioesterase 2b. [source:refseq;acc:nm\_152331]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.448\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01096\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1852\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-hydroxyisobutyryl-coenzyme a hydrolase. [source:refseq;acc:nm\_014362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.008\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.154\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01095\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1853\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tubulin-tyrosine ligase. [source:refseq;acc:nm\_153712]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.924\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.564\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1854\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b epsilon subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q13144]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.215\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.637\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0109\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1855\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g-rich sequence factor-1 (grsf-1). [source:swissprot;acc:q12849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.891\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.542\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1856\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h3 (hnrnp h3) (hnrnp 2h9). [source:swissprot;acc:p31942]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.892\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.543\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b gamma subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q9nr50]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.215\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.637\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein f (hnrnp f). [source:swissprot;acc:p52597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.545\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01089\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1859\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h (hnrnp h). [source:swissprot;acc:p31943]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.895\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.547\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1860\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h' (hnrnp h') (ftp-3). [source:swissprot;acc:p55795]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome b5 reductase b5r.2. [source:refseq;acc:nm\_016229]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
210.856\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.147\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01087\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1862\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome b5 reductase 1 (b5r.1). [source:refseq;acc:nm\_016243]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1863\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-cytochrome b5 reductase (ec 1.6.2.2) (b5r). [source:swissprot;acc:p00387]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1864\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fuse-binding protein-interacting repressor isoform b; siah binding protein 1; pyrimidine tract binding splicing factor; ro ribonucleoprotein-binding protein 1; poly-u binding splicing factor puf60. [source:refseq;acc:nm\_014281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.071\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.89\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01086\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1865\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 3 (eukaryotic translation initiation factor 2 gamma subunit) (eif-2-gamma). [source:swissprot;acc:p41091]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.639\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.046\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1866\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b delta subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q9ui10]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.725\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.133\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1867\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p38 (jtv-1 protein) (pro0992). [source:swissprot;acc:q13155]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.071\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.89\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/